» Articles » PMID: 31389726

Red Cell Distribution Width to Platelet Ratio for Liver Fibrosis: a Systematic Review and Meta-analysis of Diagnostic Accuracy

Overview
Specialty Gastroenterology
Date 2019 Aug 8
PMID 31389726
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

: Red cell distribution width to platelet ratio (RPR) may be a useful marker for the evaluation of liver fibrosis in chronic liver disease (CLD). We sought to investigate its value in fibrosis-related outcomes in a meta-analysis of diagnostic accuracy. : We searched MEDLINE (1966-2019), Clinicaltrials.gov (2008-2019), Cochrane Central Register of Controlled Trials (CENTRAL) (1999-2019), Google Scholar (2004-2019) and WHO (International Clinical Trials Register Platform) databases using a structured algorithm. The articles were assessed by Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS-2). In over 1,800 patients for each outcome, pooled sensitivity and specificity for a) significant fibrosis, b) advanced fibrosis and c) cirrhosis were: a) 0.635 and 0.769 with an AUC of 0.747, b) 0.607 and 0.783 with an AUC of 0.773, c) 0.739 and 0.768 with an AUC of 0.818 respectively. Similar results were found for chronic hepatitis B in all outcomes. Subgroup analysis indicated a high specificity for advanced fibrosis detection in primary biliary cirrhosis. Sensitivity analysis did not alter the results. : RPR is a good predictor of fibrosis, especially as severity of chronic liver disease progresses. Future research should elucidate its value in specific etiologies of chronic liver disease.

Citing Articles

Optimal use of red cell volume distribution width-to-platelet ratio to exclude cirrhosis in patients with chronic hepatitis B.

Yu H, Li C, Li M, Liang Z, Smayi A, Yang B Liver Res. 2025; 7(3):244-251.

PMID: 39958380 PMC: 11791909. DOI: 10.1016/j.livres.2023.08.006.


Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease-related compensated advanced chronic liver disease.

Zheng M, Lonardo A World J Gastroenterol. 2025; 31(3):100393.

PMID: 39839903 PMC: 11684166. DOI: 10.3748/wjg.v31.i3.100393.


Accounting for Red Cell Distribution Width Improves Risk Stratification by Commonly Used Mortality/Deterioration Risk Scores in Adult Patients Hospitalized Due to COVID-19.

Jordan A, Trkulja V, Jurin I, Marevic S, derek L, Luksic I Life (Basel). 2024; 14(10).

PMID: 39459567 PMC: 11509295. DOI: 10.3390/life14101267.


Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease.

Michalak A, Guz M, Kozicka J, Cybulski M, Jeleniewicz W, Lach T World J Gastroenterol. 2022; 28(38):5636-5647.

PMID: 36304090 PMC: 9594007. DOI: 10.3748/wjg.v28.i38.5636.


Diagnostic Accuracy of the RDW for Predicting Death in COVID-19.

Guani-Guerra E, Torres-Murillo B, Munoz-Corona C, Rodriguez-Jimenez J, Macias A, Scavo-Montes D Medicina (Kaunas). 2022; 58(5).

PMID: 35630030 PMC: 9144906. DOI: 10.3390/medicina58050613.